Drink from the hose of DIA product news; Accelrys releases modeling software;

DIA News

> Business analytics outfit SAS announced the release of the latest version of the company's SAS Drug Development software for analyzing clinical trials data. Item

> SAS also highlighted updates to JMP Clinical and JMP Genomics for analyzing clinical and genomic data, respectively. Announcement

> IMS Health revealed the launch of a web-based software product called SiteOptimizer, which is designed to enable drug and device developers to assess trial sites and investigators for clinical trials, building on the StudyOptimizer product that IMS acquired this year from DecisionView. News

> Software provider NextBio said the company has formed a partnership with Cancer Care Institute to use NextBio's platform to interpret genomic data used in the treatment of cancer patients. Release

> Octagon Research Solutions unveiled the latest release of StartingPoint, the company's software for authoring and submitting regulatory documents. Item

> CFS Clinical announced a new product called CFS InSite to support the company's services. Release

> OmniComm Systems announced a new level of integration between its clinical trials software and PharmaPros' DataFlow Manager. Item

> Merge Healthcare ($MRGE) said that it has released Merge eClinical OS, a new clinical trial operating solution. News

Non-DIA News

> Scientific software company Accelrys ($ACCL) announced the newest version of its modeling and simulation software called Discovery Studio. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.